In the future, low serum NOTCH3-ECD levels may serve as a screening tool for identifying the group of individuals with IPAH who should undergo genotyping to determine whether they truly exhibit heritable PAH. The gene discussed is NOTCH3; the disease is pulmonary arterial hypertension.